Journal: Vaccines
Article Title: Efficacy of Commercial Infectious Bronchitis Vaccines against Canadian Delmarva (DMV/1639) Infectious Bronchitis Virus Infection in Layers.
doi: 10.3390/vaccines10081194
Figure Lengend Snippet: Figure 4. Percentages of CD4+ (a) and CD8+ (b) T cells in peripheral blood mononuclear cells (PBMCs) at 5 and 12 dpi following infection with the Canadian DMV/1639 strain (IBV/Ck/Can/17– 036989). Mean percentages of CD4+ and CD8+ T cells were compared between groups using one-way ANOVA test followed by Tukey’s multiple comparisons test, and the error bars represent the SD.
Article Snippet: After centrifugating the cells as indicated above, the supernatant was discarded and the cell pellets were resuspended in the dark for 20 min at 4 ◦C using fluorescein isothiocyanate (FITC)-conjugated mouse anti-chicken CD8 (Southern Biotech, Birmingham, AL, USA) and phycoerythrin (PE)-conjugated mouse anti-chicken CD4 (Southern Biotech, Birmingham, AL, USA).
Techniques: Infection